{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:59:56Z","timestamp":1790884796030,"version":"4.1.0"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most prevalent chronic liver disease worldwide, yet no pharmacological therapy has achieved regulatory approval. Flavonoids, plant-derived polyphenols encompassing seven structural subclasses, exhibit considerable preclinical promise through multi-target mechanisms but face translational barriers owing to poor oral bioavailability and insufficient clinical validation. This review systematically evaluates 33 structurally characterized single flavonoids for their therapeutic mechanisms, pharmacological targets, and translational prospects in MASLD, integrating evidence from cellular models, diverse rodent models, and available clinical trials. A tiered evidence classification (Levels A\u2013C) was applied based on clinical data availability, multi-model validation, mechanistic depth, and study design rigor. Mechanistically, flavonoids restore hepatic lipid homeostasis by concurrently inhibiting SREBP-1c-mediated\n                    <jats:italic>de novo<\/jats:italic>\n                    lipogenesis and promoting PPAR\u03b1-driven fatty acid \u03b2-oxidation via AMPK activation; ameliorate insulin resistance through IRS-1\/PI3K\/Akt signaling; attenuate hepatic inflammation by suppressing NF-\u03baB\/NLRP3 inflammasome cascades; reinforce antioxidant defenses via Nrf2\/ARE-mediated induction of HO-1, SOD, and GPX4 with concomitant ferroptosis inhibition; enhance autophagic-lysosomal lipid clearance through TFEB nuclear translocation and Sirt1-dependent lipophagy; and remodel gut microbiota composition to fortify intestinal barrier integrity. Genistein, dihydromyricetin, quercetin, and kaempferol exemplify polypharmacological engagement across multiple pathways. Despite robust mechanistic evidence, oral bioavailability remains limited to 1%\u20135% owing to poor aqueous solubility, extensive phase II conjugation, and food-matrix interactions. Emerging strategies\u2014carbamate prodrugs, nanoliposomes, biomimetic nanoemulsions, and colon-targeted nanoparticles\u2014demonstrate feasibility in surmounting these barriers. Clinical evidence reveals compound-specific efficacy profiles: hesperidin reduces steatosis and transaminases; genistein improves insulin sensitivity; naringenin ameliorates lipid profiles without altering fibrosis markers. Critical appraisal identifies persistent limitations including small sample sizes, predominant reliance on male animals, short intervention durations, and absence of biopsy-confirmed endpoints. Future research must prioritize rigorous multicenter randomized controlled trials with optimized formulations, comparative efficacy studies, systematic safety evaluations, and multi-omics integration to bridge the translational gap toward evidence-based flavonoid therapeutics for MASLD.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1878277","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:34:50Z","timestamp":1784871290000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Flavonoids in MASLD: preclinical mechanisms, pharmacological targets, and translational challenges"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhonghai","family":"Dao","sequence":"first","affiliation":[{"name":"College of Biological Science and Food Engineering, Southwest Forestry University","place":["Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jishen","family":"Li","sequence":"additional","affiliation":[{"name":"People\u2019s Hospital of Fengqing County","place":["Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Liu","sequence":"additional","affiliation":[{"name":"People\u2019s Hospital of Fengqing County","place":["Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqiong","family":"Niu","sequence":"additional","affiliation":[{"name":"College of Biological Science and Food Engineering, Southwest Forestry University","place":["Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Xiao","sequence":"additional","affiliation":[{"name":"College of Biological Science and Food Engineering, Southwest Forestry University","place":["Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrun","family":"Dong","sequence":"additional","affiliation":[{"name":"College of Biological Science and Food Engineering, Southwest Forestry University","place":["Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3946320221137435","DOI":"10.1177\/03946320221137435","article-title":"Luteolin loaded on zinc oxide nanoparticles ameliorates non-alcoholic fatty liver disease associated with insulin resistance in diabetic rats via regulation of PI3K\/AKT\/FoxO1 pathway","volume":"36","author":"Ahmed","year":"2022","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/biof.1428","article-title":"Butein protects the nonalcoholic fatty liver through mitochondrial reactive oxygen species attenuation in rats","volume":"44","author":"Alshammari","year":"2018","journal-title":"BioFactors Oxf. Engl"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.clnu.2017.05.08","article-title":"Genistein supplementation improves insulin resistance and inflammatory state non-alcoholic fatty liver patients: a randomized, controlled trial","volume":"37","author":"Amanat","year":"","journal-title":"Clin. Nutr. Edinb. Scotl."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.clnu.2017.05.028","article-title":"Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: a randomized, controlled trial","volume":"37","author":"Amanat","year":"","journal-title":"Clin. Nutr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/clpt.2012.110","article-title":"Nrf2: a potential target for new therapeutics in liver disease","volume":"92","author":"Bataille","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.ajcnut.2024.09.022","article-title":"A flavonoid-rich diet is associated with lower risk and improved imaging biomarkers of nonalcoholic fatty liver disease: a prospective cohort study","volume":"120","author":"Bell","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1172\/JCI41636","article-title":"The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans","volume":"122","author":"Benhamed","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3390\/ph16101407","article-title":"Flavonoids in the spotlight: bridging the gap between physicochemical properties and formulation strategies","volume":"16","author":"Berga","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism - Clin. Exp."},{"key":"B11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","article-title":"Gut microbial metabolites in obesity, NAFLD and T2DM","volume":"15","author":"Canfora","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"109414","DOI":"10.1016\/j.jnutbio.2023.109414","article-title":"Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-Mediated hepatic mitophagy","volume":"120","author":"Cao","year":"","journal-title":"J. Nutr. Biochem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1002\/ptr.7932","article-title":"Preventive and therapeutic effects of natural products and herbal extracts on nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"37","author":"Cao","year":"","journal-title":"Phytotherapy Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","article-title":"AMPK signalling in health and disease","volume":"45","author":"Carling","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.biopha.2017.04.125","article-title":"Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPAR\u03b1\/AdipoR2, in vivo and in vitro","volume":"91","author":"Chen","year":"2017","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2015.05.009","article-title":"Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial","volume":"99","author":"Chen","year":"2015","journal-title":"Pharmacol. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"111927","DOI":"10.1016\/j.biopha.2021.111927","article-title":"Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease","volume":"142","author":"Chen","year":"2021","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7731","DOI":"10.1080\/10408398.2021.1917508","article-title":"Absorption, metabolism and bioavailability of flavonoids: a review","volume":"62","author":"Chen","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"108391","DOI":"10.1016\/j.pharmthera.2023.108391","article-title":"PPAR-\u03b3 signaling in nonalcoholic fatty liver disease: pathogenesis and therapeutic targets","volume":"245","author":"Chen","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2025.2466145","article-title":"Buddleoside alleviates nonalcoholic steatohepatitis by targeting the AMPK-TFEB signaling pathway","author":"Chen","year":"2025","journal-title":"Autophagy"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/ptr.6406","article-title":"Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled, double-blind clinical trial","volume":"33","author":"Cheraghpour","year":"2019","journal-title":"Phytother. Res. PTR"},{"key":"B21","doi-asserted-by":"publisher","first-page":"104954","DOI":"10.1016\/j.jff.2022.104954","article-title":"Fisetin represses oxidative stress and mitochondrial dysfunction in NAFLD through suppressing GRP78-mediated endoplasmic reticulum (ER) stress","volume":"90","author":"Dai","year":"2022","journal-title":"J. Funct. Food."},{"key":"B22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tibs.2018.01.005","article-title":"SREBPs in lipid metabolism, insulin signaling, and beyond","volume":"43","author":"DeBose-Boyd","year":"2018","journal-title":"Trends biochem. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e22261","DOI":"10.1096\/fj.202101567R","article-title":"Alpinetin inhibits macrophage infiltration and atherosclerosis by improving the thiol redox state: requirement of GSk3\u03b2\/fyn-dependent Nrf2 activation","volume":"36","author":"Dong","year":"2022","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/jgh.13884","article-title":"Effects of calycosin against high fat diet-induced nonalcoholic fatty liver disease in mice","volume":"33","author":"Duan","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.foodchem.2014.06.022","article-title":"Trilobatin attenuates the LPS-mediated inflammatory response by suppressing the NF-\u03baB signaling pathway","volume":"166","author":"Fan","year":"2015","journal-title":"Food Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.1021\/acs.jafc.3c09601","article-title":"Puerarin induces macrophage M2 polarization to exert antinonalcoholic steatohepatitis pharmacological activity via the activation of autophagy","volume":"72","author":"Fang","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"B135","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bcp.2017.04.014","article-title":"Apigenin, a modulator of PPAR\u03b3, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation","volume":"136","author":"Feng","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/15548627.2021.1895658","article-title":"The m\u00e9nage \u00e0 trois of autophagy, lipid droplets and liver disease","volume":"18","author":"Filali-Mouncef","year":"2022","journal-title":"Autophagy"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/cells9071638","article-title":"Peroxisome proliferator-activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease","volume":"9","author":"Fougerat","year":"2020","journal-title":"Cells"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1002\/ptr.7762","article-title":"Baicalin ameliorates high fat diet-induced nonalcoholic fatty liver disease in mice via adenosine monophosphate-activated protein kinase-mediated regulation of SREBP1\/Nrf2\/NF-\u03baB signaling pathways","volume":"37","author":"Gao","year":"2023","journal-title":"Phytother. Res. PTR"},{"key":"B30","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1142\/S0192415X25500338","article-title":"Mechanisms of dihydromyricetin for improving hepatic fibrosis through the integration of metabolomics and gut microbiota","volume":"53","author":"Gao","year":"2025","journal-title":"Am. J. Chin. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","article-title":"AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance","volume":"66","author":"Garcia","year":"2017","journal-title":"Mol. Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1053\/j.gastro.2020.02.020","article-title":"Metabolic inflammation-a role for hepatic inflammatory pathways as drivers of comorbidities in nonalcoholic fatty liver disease?","volume":"158","author":"Gehrke","year":"2020","journal-title":"Gastroenterology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2337\/dsi23-0012","article-title":"Pharmacological approaches to nonalcoholic fatty liver disease: current and future therapies","volume":"37","author":"Genua","year":"2024","journal-title":"Diabetes Spectr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1080\/10408398.2021.1966738","article-title":"Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut\u2013liver axis","volume":"63","author":"Han","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Sci. (N. Y. N.Y.)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.38212\/2224-6614.3269","article-title":"Apigenin ameliorates hepatic lipid accumulation by activating the autophagy-mitochondria pathway","volume":"29","author":"Hsu","year":"2021","journal-title":"J. Food Drug Anal."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3390\/molecules30051184","article-title":"Botanical flavonoids: efficacy, absorption, metabolism and advanced pharmaceutical technology for improving bioavailability","volume":"30","author":"Hu","year":"2025","journal-title":"Molecules"},{"key":"B40","doi-asserted-by":"publisher","first-page":"153412","DOI":"10.1016\/j.phymed.2020.153412","article-title":"Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe-\/-mice: role of SIRT1","volume":"81","author":"Hua","year":"2021","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbrc.2019.08.139","article-title":"Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice","volume":"519","author":"Inamdar","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/nu15020350","article-title":"Novel therapeutic potentials of taxifolin for obesity-induced hepatic steatosis, fibrogenesis, and tumorigenesis","volume":"15","author":"Inoue","year":"2023","journal-title":"Nutrients"},{"key":"B44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbrc.2022.12.014","article-title":"The natural flavone acacetin protects against high-fat diet-induced lipid accumulation in the liver via the endoplasmic reticulum stress\/ferroptosis pathway","volume":"640","author":"Jiang","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/biom9050174","article-title":"Fisetin and quercetin: promising flavonoids with chemopreventive potential","volume":"9","author":"Kashyap","year":"2019","journal-title":"Biomolecules"},{"key":"B46","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in nonalcoholic fatty liver disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatol. Balt. Md"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3390\/ph18081162","article-title":"Chrysin: a comprehensive review of its pharmacological properties and therapeutic potential","volume":"18","author":"Kurkiewicz","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/hep.32221","article-title":"Breviscapine alleviates NASH by inhibiting TGF-\u03b2-activated kinase 1-dependent signaling","volume":"76","author":"Lan","year":"2022","journal-title":"Hepatol. Balt. Md"},{"key":"B49","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.intimp.2015.06.015","article-title":"Sappanone a exhibits anti-inflammatory effects via modulation of Nrf2 and NF-\u03baB","volume":"28","author":"Lee","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis","volume":"116","author":"Lefebvre","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1039\/D0FO02736G","article-title":"Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"key":"B52","doi-asserted-by":"publisher","first-page":"878776","DOI":"10.3389\/fphar.2022.878776","article-title":"Role of licochalcone a in potential pharmacological therapy: a review","volume":"13","author":"Li","year":"","journal-title":"Front. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"11224","DOI":"10.1021\/acs.jafc.2c02334","article-title":"Effect of hesperidin supplementation on liver metabolomics and gut microbiota in a high-fat diet-induced NAFLD mice model","volume":"70","author":"Li","year":"","journal-title":"J. Agric. Food Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e2300480","DOI":"10.1002\/mnfr.202300480","article-title":"Does flavonoid supplementation alleviate non-alcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials","volume":"67","author":"Li","year":"","journal-title":"Mol. Nutr. Food Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.3390\/biomedicines11123280","article-title":"SREBP regulation of lipid metabolism in liver disease, and therapeutic strategies","volume":"11","author":"Li","year":"","journal-title":"Biomedicines"},{"key":"B56","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ajcnut.2024.07.013","article-title":"Quercetin intervention reduced hepatic fat deposition in patients with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled crossover clinical trial","volume":"120","author":"Li","year":"","journal-title":"Am. J. Clin. Nutr."},{"key":"B57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"","journal-title":"Lipids Health Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/cells8050447","article-title":"Protective effects of licochalcone a ameliorates obesity and non-alcoholic fatty liver disease via promotion of the sirt-1\/AMPK pathway in mice fed a high-fat diet","volume":"8","author":"Liou","year":"2019","journal-title":"Cells"},{"key":"B59","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.biopha.2017.04.130","article-title":"Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats","volume":"91","author":"Liu","year":"2017","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"B60","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3892\/ijmm.2018.3651","article-title":"Breviscapine ameliorates CCl4-induced liver injury in mice through inhibiting inflammatory apoptotic response and ROS generation","volume":"42","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"106208","DOI":"10.1016\/j.intimp.2020.106208","article-title":"Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice","volume":"80","author":"Liu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"104655","DOI":"10.1016\/j.jff.2021.104655","article-title":"Kaempferol prevents the progression from simple steatosis to non-alcoholic steatohepatitis by inhibiting the NF-\u03baB pathway in oleic acid-induced HepG2 cells and high-fat diet-induced rats","volume":"85","author":"Liu","year":"2021","journal-title":"J. Funct. Foods"},{"key":"B63","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1208\/s12249-022-02255-3","article-title":"Development, characterization, and investigation of In vivo targeted delivery efficacy of luteolin-loaded, eudragit S100-coated mPEG-PLGA nanoparticles","volume":"23","author":"Liu","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"B64","doi-asserted-by":"publisher","first-page":"155437","DOI":"10.1016\/j.phymed.2024.155437","article-title":"Rutin ameliorated lipid metabolism dysfunction of diabetic NAFLD via AMPK\/SREBP1 pathway","volume":"126","author":"Liu","year":"2024","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","first-page":"9208","DOI":"10.1039\/d0fo00949k","article-title":"Apigenin induced autophagy and stimulated autophagic lipid degradation","volume":"11","author":"Lu","year":"2020","journal-title":"Food Funct."},{"key":"B67","doi-asserted-by":"publisher","first-page":"946360","DOI":"10.3389\/fphar.2022.946360","article-title":"Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver--linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"117883","DOI":"10.1016\/j.jep.2024.117883","article-title":"Calycosin enhances treg differentiation for alleviating skin inflammation in atopic dermatitis","volume":"326","author":"Ma","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev-nutr-071813-105336","article-title":"Autophagy and lipid droplets in the liver","volume":"35","author":"Martinez-Lopez","year":"2015","journal-title":"Annu. Rev. Nutr."},{"key":"B71","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1080\/10408398.2021.1898333","article-title":"The fate of flavonoids after oral administration: a comprehensive overview of its bioavailability","volume":"62","author":"Naeem","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B72","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MEG.0000000000002323","article-title":"Effects of naringenin supplementation on cardiovascular risk factors in overweight\/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial","volume":"34","author":"Naeini","year":"2022","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e14852","DOI":"10.1111\/ijcp.14852","article-title":"Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight\/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial","volume":"75","author":"Namkhah","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"B74","doi-asserted-by":"publisher","first-page":"35127","DOI":"10.1039\/d3ra06537e","article-title":"Co-encapsulated astaxanthin and kaempferol nanoparticles: fabrication, characterization, and their potential synergistic effects on treating non-alcoholic fatty liver disease","volume":"13","author":"Oanh","year":"2023","journal-title":"RSC Adv."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e31006","DOI":"10.1002\/jcp.31006","article-title":"Bacterial biosynthesis of flavonoids: overview, current biotechnology applications, challenges, and prospects","volume":"239","author":"Okoye","year":"2024","journal-title":"J. Cell. Physiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.3390\/molecules28041734","article-title":"The anti-obesity and anti-steatotic effects of chrysin in a rat model of obesity mediated through modulating the hepatic AMPK\/mTOR\/lipogenesis pathways","volume":"28","author":"Oriquat","year":"2023","journal-title":"Mol. (Basel Switz.)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mam.2018.01.001","article-title":"Flavonoids and the gastrointestinal tract: local and systemic effects","volume":"61","author":"Oteiza","year":"2018","journal-title":"Mol. Asp. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: an overview","volume":"5","author":"Panche","year":"2016","journal-title":"J. Nutr. Sci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1080\/10408398.2020.1753165","article-title":"Absorption, metabolism, and bioactivity of vitexin: recent advances in understanding the efficacy of an important nutraceutical","volume":"61","author":"Peng","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/jsfa.5697","article-title":"The flavonoid paradox: conjugation and deconjugation as key steps for the biological activity of flavonoids","volume":"92","author":"Perez-Vizcaino","year":"2012","journal-title":"J. Sci. Food Agric."},{"key":"B82","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2016.11.037","article-title":"Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation","volume":"102","author":"Porras","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"100973","DOI":"10.1016\/j.mam.2021.100973","article-title":"Autophagy in liver diseases: a review","volume":"82","author":"Qian","year":"2021","journal-title":"Mol. Asp. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"102062","DOI":"10.1016\/j.toxrep.2025.102062","article-title":"Naringin ameliorates high-fat diet-induced hepatotoxicity and dyslipidemia in experimental rat model via modulation of anti-oxidant enzymes, AMPK and SERBP-1c signaling pathways","volume":"14","author":"Sarkar","year":"2025","journal-title":"Toxicol. Rep."},{"key":"B86","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1017\/S002966511000162X","article-title":"Flavonoids as anti-inflammatory agents","volume":"69","author":"Serafini","year":"2010","journal-title":"Proc. Nutr. Soc."},{"key":"B87","doi-asserted-by":"publisher","first-page":"6999","DOI":"10.1039\/c9fo01733j","article-title":"In vivo formed metabolites of polyphenols and their biological efficacy","volume":"10","author":"Serreli","year":"2019","journal-title":"Food Funct."},{"key":"B88","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.1080\/10408398.2021.1901650","article-title":"Influence of food matrix and food processing on the chemical interaction and bioaccessibility of dietary phytochemicals: a review","volume":"62","author":"Shahidi","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B89","doi-asserted-by":"publisher","first-page":"14732","DOI":"10.1021\/acs.jafc.2c06212","article-title":"Structural insights into amelioration effects of quercetin and its glycoside derivatives on NAFLD in mice by modulating the gut microbiota and host metabolism","volume":"70","author":"Shi","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism","volume":"458","author":"Singh","year":"2009","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1017\/S0954422424000350","article-title":"A comprehensive review on the impact of hesperidin and its aglycone hesperetin on metabolic dysfunction-associated steatotic liver disease and other liver disorders","volume":"38","author":"Sivaslioglu","year":"2025","journal-title":"Nutr. Res. Rev."},{"key":"B92","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/biomedicines10030524","article-title":"The role of gut\u2013liver axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC","volume":"10","author":"Song","year":"2022","journal-title":"Biomedicines"},{"key":"B93","doi-asserted-by":"publisher","first-page":"107438","DOI":"10.1016\/j.intimp.2021.107438","article-title":"Hyperoside attenuates non-alcoholic fatty liver disease through targeting Nr4A1 in macrophages","volume":"94","author":"Sun","year":"","journal-title":"Int. Immunopharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"109641","DOI":"10.1016\/j.celrep.2021.109641","article-title":"Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota","volume":"36","author":"Sun","year":"","journal-title":"Cell Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1005312","DOI":"10.3389\/fphar.2022.1005312","article-title":"Natural flavonoids: potential therapeutic strategies for non-alcoholic fatty liver disease","volume":"13","author":"Tan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr. Biol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrgastro.2016.185","article-title":"Autophagy in the liver: functions in health and disease","volume":"14","author":"Ueno","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"8535","DOI":"10.1080\/10408398.2021.1929822","article-title":"Flavonoids and cellular stress: a complex interplay affecting human health","volume":"62","author":"Vissenaekens","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B100","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1021\/acs.jafc.8b01691","article-title":"Genistein ameliorates non-alcoholic fatty liver disease by targeting the thromboxane A2 pathway","volume":"66","author":"Wang","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"B101","doi-asserted-by":"publisher","first-page":"108214","DOI":"10.1016\/j.jnutbio.2019.07.005","article-title":"Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy","volume":"73","author":"Wang","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.1002\/ptr.8013","article-title":"Galangin: a food-derived flavonoid with therapeutic potential against a wide spectrum of diseases","volume":"37","author":"Wang","year":"","journal-title":"Phytother. Res. PTR"},{"key":"B104","doi-asserted-by":"publisher","first-page":"106925","DOI":"10.1016\/j.phrs.2023.106925","article-title":"Natural products in non-alcoholic fatty liver disease (NAFLD): novel lead discovery for drug development","volume":"196","author":"Wang","year":"","journal-title":"Pharmacol. Res."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.3390\/nu16142343","article-title":"Hesperetin alleviated experimental colitis via regulating ferroptosis and gut microbiota","volume":"16","author":"Wang","year":"2024","journal-title":"Nutrients"},{"key":"B106","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jare.2025.05.014","article-title":"Hyperoside modulates bile acid and fatty acid metabolism, presenting a potentially promising treatment for non-alcoholic fatty liver disease","author":"Wang","year":"2025","journal-title":"J. Adv. Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cbi.2016.11.026","article-title":"Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells","volume":"261","author":"Wei","year":"2017","journal-title":"Chem.-Biol. Interact."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s41401-023-01056-z","article-title":"Bavachin protects against diet-induced hepatic steatosis and obesity in mice","volume":"44","author":"Wei","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"B109","doi-asserted-by":"publisher","first-page":"103910","DOI":"10.1016\/j.drudis.2024.103910","article-title":"NAFLD and NASH: etiology, targets and emerging therapies","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"key":"B110","doi-asserted-by":"publisher","first-page":"9317","DOI":"10.3390\/ijms24119317","article-title":"The pharmacological efficacy of baicalin in inflammatory diseases","volume":"24","author":"Wen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/1541-4337.12351","article-title":"The bioavailability, transport, and bioactivity of dietary flavonoids: a review from a historical perspective","volume":"17","author":"Williamson","year":"2018","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"B112","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.2147\/DDDT.S227499","article-title":"Hesperidin: a therapeutic agent for obesity","volume":"13","author":"Xiong","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3389\/fphar.2018.01428","article-title":"The role of Nrf2 in liver disease: novel molecular mechanisms and therapeutic approaches","volume":"9","author":"Xu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"e13724","DOI":"10.1111\/obr.13724","article-title":"Inflammation-mediated metabolic regulation in adipose tissue","volume":"25","author":"Xu","year":"2024","journal-title":"Obes. Rev."},{"key":"B115","doi-asserted-by":"publisher","first-page":"10186","DOI":"10.1039\/D2FO01682F","article-title":"Nobiletin mitigates NAFLD via lipophagy and inflammation","volume":"13","author":"Yang","year":"2022","journal-title":"Food Funct."},{"key":"B116","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1186\/s12967-023-04790-4","article-title":"Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis","volume":"21","author":"Yang","year":"2023","journal-title":"J. Transl. Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-024-05060-7","article-title":"Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK\/PGC-1\u03b1 and PPAR\u03b1-mediated autophagy pathway","volume":"22","author":"Yang","year":"2024","journal-title":"J. Transl. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"116694","DOI":"10.1016\/j.biopha.2024.116694","article-title":"Kaempferol efficacy in metabolic diseases: molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis","volume":"175","author":"Yao","year":"2024","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"B119","doi-asserted-by":"publisher","first-page":"e18321","DOI":"10.1016\/j.heliyon.2023.e18321","article-title":"Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis","volume":"9","author":"Ye","year":"2023","journal-title":"Heliyon"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.biopha.2019.01.004","article-title":"Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats","volume":"111","author":"Yin","year":"2019","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"B121","doi-asserted-by":"publisher","first-page":"570903","DOI":"10.2147\/IJN.S570903","article-title":"High dihydromyricetin loaded biomimetic nanoemulsion ameliorated early nonalcoholic fatty liver disease by hepatic ferroptosis inhibition","volume":"21","author":"Yin","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"B122","doi-asserted-by":"publisher","first-page":"112836","DOI":"10.1016\/j.biopha.2022.112836","article-title":"Formononetin protects against inflammation associated with cerebral ischemia-reperfusion injury in rats by targeting the JAK2\/STAT3 signaling pathway","volume":"149","author":"Yu","year":"2022","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"B123","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.phrs.2018.08.002","article-title":"Naringenin as a potential immunomodulator in therapeutics","volume":"135","author":"Zeng","year":"2018","journal-title":"Pharmacol. Res."},{"key":"B124","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/ars.2017.7172","article-title":"Dihydromyricetin ameliorates nonalcoholic fatty liver disease by improving mitochondrial respiratory capacity and redox homeostasis through modulation of SIRT3 signaling","volume":"30","author":"Zeng","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"B125","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.2147\/DDDT.S258187","article-title":"Galangin improved non-alcoholic fatty liver disease in mice by promoting autophagy","volume":"14","author":"Zhang","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"B126","doi-asserted-by":"publisher","first-page":"175291","DOI":"10.1016\/j.ejphar.2022.175291","article-title":"Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation","volume":"933","author":"Zhang","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"11124","DOI":"10.1080\/10408398.2023.2232880","article-title":"Food matrix-flavonoid interactions and their effect on bioavailability","volume":"64","author":"Zhang","year":"","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1336232","DOI":"10.3389\/fphar.2024.1336232","article-title":"Synthesis and biological evaluation of the novel chrysin prodrug for non-alcoholic fatty liver disease treatment","volume":"15","author":"Zhang","year":"","journal-title":"Front. Pharmacol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"119119","DOI":"10.1016\/j.jep.2024.119119","article-title":"Eriocitrin ameliorates hepatic fibrosis and inflammation: the involvement of PPAR\u03b1\u2010mediated NLRP1\/NLRC4 inflammasome signaling cascades","volume":"338","author":"Zhang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/ptr.5083","article-title":"Puerarin: a review of pharmacological effects","volume":"28","author":"Zhou","year":"2014","journal-title":"Phytother. Res. PTR"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.biopha.2017.10.035","article-title":"Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism","volume":"97","author":"Zhou","year":"2018","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"B132","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12986-021-00589-6","article-title":"Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect","volume":"18","author":"Zhou","year":"2021","journal-title":"Nutr. Metab."},{"key":"B133","doi-asserted-by":"publisher","first-page":"156341","DOI":"10.1016\/j.phymed.2024.156341","article-title":"Sappanone a alleviates metabolic dysfunction-associated steatohepatitis by decreasing hepatocyte lipotoxicity via targeting Mup3 in mice","volume":"136","author":"Zhu","year":"2025","journal-title":"Phytomedicine"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1878277\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:34:51Z","timestamp":1784871291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1878277\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":137,"alternative-id":["10.3389\/fphar.2026.1878277"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1878277","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"article-number":"1878277"}}